DANAHER CORPORATION (NYSE:DHR) Files An 8-K Results of Operations and Financial Condition

DANAHER CORPORATION (NYSE:DHR) Files An 8-K Results of Operations and Financial Condition

Story continues below

ITEM 2.02

RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On April 20, 2017, Danaher Corporation (Danaher) issued a press
release announcing financial results for the quarter ended March
31, 2017. A copy of the release is furnished herewith as Exhibit
99.1 and incorporated by reference herein. This Current Report on
Form 8-K and the press release attached hereto are being
furnished by Danaher to Item 2.02 of Form 8-K.
This information shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference
in such a filing.
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
(c)
Exhibits:
Exhibit No.
Description
99.1
Press releaseDanaher Reports First Quarter 2017 Results


About DANAHER CORPORATION (NYSE:DHR)

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world’s food supply, improve packaging design and quality, and verify pharmaceutical dosages.

DANAHER CORPORATION (NYSE:DHR) Recent Trading Information

DANAHER CORPORATION (NYSE:DHR) closed its last trading session down -0.10 at 86.44 with 2,583,421 shares trading hands.

An ad to help with our costs